Elijah Saunders

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular disease
    Elijah Saunders
    Division of Cardiology, Section of Hypertension, University of Maryland School of Medicine, Baltimore, MD
    J Clin Hypertens (Greenwich) 5:12-7. 2003
  2. doi request reprint Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy: race and ethnicity considerations
    Elijah Saunders
    Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Cardiol Rev 16:82-8. 2008
  3. ncbi request reprint The efficacy and tolerability of nebivolol in hypertensive African American patients
    Elijah Saunders
    Section of Hypertension, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 9:866-75. 2007
  4. ncbi request reprint Managing hypertension in African-American patients
    Elijah Saunders
    Division of Cardiology, University of Maryland School of Medicine, 419 West Redwood Street, Baltimore, MD 21201 1734, USA
    J Clin Hypertens (Greenwich) 6:19-25. 2004
  5. ncbi request reprint Building on the specialist's antihypertensive treatment recommendation: it's just the beginning
    Elijah Saunders
    University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 8:31-9. 2006
  6. doi request reprint Readmissions after unauthorized discharges in the cardiovascular setting
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 49:215-24. 2011
  7. pmc The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population
    Wallace Johnson
    School of Medicine, University of Maryland, Baltimore, MD, USA
    J Clin Hypertens (Greenwich) 13:563-70. 2011
  8. pmc Social networks help control hypertension
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 15:34-40. 2013
  9. ncbi request reprint Diabetes knowledge in a high risk urban population
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
    Ethn Dis 21:485-9. 2011
  10. ncbi request reprint Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics
    Nneka C Onwudiwe
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, Maryland 21201, USA
    Ethn Dis 21:27-32. 2011

Research Grants

Detail Information

Publications36

  1. ncbi request reprint Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular disease
    Elijah Saunders
    Division of Cardiology, Section of Hypertension, University of Maryland School of Medicine, Baltimore, MD
    J Clin Hypertens (Greenwich) 5:12-7. 2003
    ..Although further confirmation in additional clinical trials is required, increased use of these agents in African Americans will likely result in a reduction in target organ damage...
  2. doi request reprint Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy: race and ethnicity considerations
    Elijah Saunders
    Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Cardiol Rev 16:82-8. 2008
    ..Thus, understanding and overcoming race and ethnicity-related treatment disparities should lead to significant clinical improvements in these under-served populations...
  3. ncbi request reprint The efficacy and tolerability of nebivolol in hypertensive African American patients
    Elijah Saunders
    Section of Hypertension, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 9:866-75. 2007
    ..Nebivolol monotherapy provides antihypertensive efficacy, with few significant adverse effects, in hypertensive African Americans...
  4. ncbi request reprint Managing hypertension in African-American patients
    Elijah Saunders
    Division of Cardiology, University of Maryland School of Medicine, 419 West Redwood Street, Baltimore, MD 21201 1734, USA
    J Clin Hypertens (Greenwich) 6:19-25. 2004
    ..Based on these findings, recommendations are made for the optimal clinical management of hypertension in African-American patients...
  5. ncbi request reprint Building on the specialist's antihypertensive treatment recommendation: it's just the beginning
    Elijah Saunders
    University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 8:31-9. 2006
    ..With the availability of effective and safe antihypertensive drug therapies, including fixed-dose combinations, a BP goal of <140/90 mm Hg should be achievable in most patients...
  6. doi request reprint Readmissions after unauthorized discharges in the cardiovascular setting
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 49:215-24. 2011
    ....
  7. pmc The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population
    Wallace Johnson
    School of Medicine, University of Maryland, Baltimore, MD, USA
    J Clin Hypertens (Greenwich) 13:563-70. 2011
    ..Additional research should be conducted to evaluate whether the use of certified hypertension educators in collaboration with physicians will result in a similar blood pressure reduction...
  8. pmc Social networks help control hypertension
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 15:34-40. 2013
    ..The clustering of patients in social networks around hypertension education has a positive impact on the management of hypertension in minority populations and may help address cardiovascular health disparities...
  9. ncbi request reprint Diabetes knowledge in a high risk urban population
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
    Ethn Dis 21:485-9. 2011
    ..0104). The study indicated that patients who are exposed to the educational program end up with better knowledge on all counts, than patients who just go through the health care system in the course of usual care for diabetes...
  10. ncbi request reprint Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics
    Nneka C Onwudiwe
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, Maryland 21201, USA
    Ethn Dis 21:27-32. 2011
    ..Our goal was to explore patients' perceptions about barriers to self-management of diabetes that could possibly help explain poor health outcomes among minority patients...
  11. pmc Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin
    Fadia T Shaya
    Outcomes Research Epidemiology Center on Drugs and Public Policy University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Natl Med Assoc 97:493-7. 2005
    ..To identify patient characteristics that are associated with the incidence of thiadolidinediones (TZDs) or metformin prescnbing in Medicaid managed care plans...
  12. ncbi request reprint A qualitative evaluation of a citywide Community Health Partnership program
    C Daniel Mullins
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Saratoga Building, 12th Floor, 220 Arch St, Baltimore, MD 21201, USA
    J Natl Med Assoc 104:53-60. 2012
    ..Through stakeholder engagement, many more communities beyond Baltimore can become better networked to help patients navigate the health care system and improve their health...
  13. ncbi request reprint Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study
    Elijah Saunders
    Division of Cardiology, Section of Hypertension, University of Maryland School of Medicine Baltimore, MD, USA
    J Clin Hypertens (Greenwich) 10:27-33. 2008
    ..In conclusion, a significant correlation may exist between certain clinical/demographic characteristics and the extent of the therapeutic response with irbesartan/hydrochlorothiazide treatment...
  14. ncbi request reprint Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease
    Ebere Chukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Ethn Dis 19:172-8. 2009
    ..Disparities in discharges AMA have not been examined among patients with cardiovascular disease, nor has the moderating role of hospital quality been studied...
  15. pmc Reasons for discharges against medical advice: a qualitative study
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Qual Saf Health Care 19:420-4. 2010
    ..The objective of this study is to identify the reasons for DAMA based on patient and multicategory provider focus-group interviews (FGIs)...
  16. ncbi request reprint A perspective on African American participation in clinical trials
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA
    Contemp Clin Trials 28:213-7. 2007
    ....
  17. ncbi request reprint Hypertension in black Americans as a special population: why so special?
    David Stewart
    Section of Hypertension, Division of Cardiology, University of Maryland School of Medicine, 419 West Redwood Street, Baltimore, MD 21201, USA
    Curr Cardiol Rep 8:405-10. 2006
    ..This article reviews the varied aspects of hypertension detection, treatment, and control as they relate to the special population of black Americans...
  18. ncbi request reprint Addressing cardiovascular disparities through community interventions
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Ethn Dis 16:138-44. 2006
    ..To identify the components and impact of intervention programs aimed at reducing cardiovascular disparities...
  19. ncbi request reprint Health care cost of analgesic use in hypertensive patients
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Clin Ther 26:285-93. 2004
    ..Hypertension is one of the most frequently diagnosed chronic medical conditions in the United States and imposes a substantial financial and social burden on Americans...
  20. doi request reprint Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores
    Fadia T Shaya
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 5:625-32. 2005
    ..Misclassification bias was accounted for by adjusting for length of drug exposure...
  21. ncbi request reprint Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
    John M Flack
    Department of Internal Medicine, Wayne State University, Detroit, Michigan 48201, USA
    J Am Coll Cardiol 41:1148-55. 2003
    ..The purpose of this study was to evaluate the efficacy and tolerability of monotherapy with the selective aldosterone blocker eplerenone in both black and white patients with hypertension...
  22. ncbi request reprint Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
    Janice G Douglas
    Case Western Reserve University, Department of Medicine, Room W 165, 10900 Euclid Ave, Cleveland, Ohio 44106, USA
    Arch Intern Med 163:525-41. 2003
  23. pmc Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial
    Elizabeth O Ofili
    Morehouse School of Medicine, Atlanta, Georgia 30310, USA
    J Womens Health (Larchmt) 17:931-8. 2008
    ....
  24. ncbi request reprint Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension
    William B White
    Section of Hypertension and Clinical Pharmacology, Department of Medicine, University of Connecticut School of Medicine, 263 Farmngton Avenue, Farmington, CT 06032, USA
    Am J Hypertens 16:739-45. 2003
    ....
  25. ncbi request reprint Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group
    Sidney C Smith
    Circulation 111:e134-9. 2005
  26. ncbi request reprint Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes
    James R Sowers
    University of Missouri Columbia and Harry S Truman VA Medical Center, 65212, USA
    J Clin Hypertens (Greenwich) 8:470-80. 2006
    ..Irbesartan/HCTZ fixed combinations achieved SBP goals in over half of the T2DM patients and nearly three quarters of patients with the metabolic syndrome, with SBP uncontrolled on antihypertensive monotherapy...
  27. doi request reprint Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial
    John M Flack
    Department of Medicine, Wayne State University, Detroit, MI 48201, USA
    Mayo Clin Proc 83:35-45. 2008
    ..To investigate the efficacy and safety of single-pill amlodipine/atorvastatin therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African Americans...
  28. pmc Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy
    Elizabeth O Ofili
    Clinical Research Center, Morehouse School of Medicine, Atlanta, GA 30310, USA
    J Natl Med Assoc 98:618-26. 2006
    ..In conclusion, irbesartan/HCTZ treatment provided SBP/DBP goal attainment in approximately two-thirds of Caucasian, African-American and Hispanic/Latino patients with SBP uncontrolled on antihypertensive monotherapy...
  29. ncbi request reprint The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial
    Joel M Neutel
    Orange County Research Center, Tustin, CA 92780, USA
    J Clin Hypertens (Greenwich) 7:578-86. 2005
    ..Treatments were well tolerated. This irbesartan/HCTZ treatment regimen achieved SBP goals in more than 75% of patients uncontrolled on monotherapy...
  30. ncbi request reprint Hypertension-related morbidity and mortality in African Americans--why we need to do better
    Keith C Ferdinand
    Heartbeats Life Center, Xavier University College of Pharmacy, New Orleans, LA, USA
    J Clin Hypertens (Greenwich) 8:21-30. 2006
    ..These comorbidities are more common in African Americans and indicate the potential need for initial therapy with more than one agent or a combination of agents in one pill...
  31. ncbi request reprint Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial
    Evan Mokwe
    Department of Internal Medicine, Wayne State University, Detroit, Mich 48201, USA
    Hypertension 43:1202-7. 2004
    ....
  32. ncbi request reprint Racial disparities in hypertension prevalence, awareness, and management
    Robin P Hertz
    US Outcomes Research Population Studies, Pfizer Global Pharmaceuticals, New York, NY 10017, USA
    Arch Intern Med 165:2098-104. 2005
    ..Effectively reducing cardiovascular disease disparities requires identifying and reducing disparities in risk factors. Improved understanding of hypertension disparities is critical...
  33. ncbi request reprint The metabolic syndrome: recognition and management
    W Dallas Hall
    Emory University School of Medicine, Atlanta, GA, USA
    Dis Manag 9:16-33. 2006
    ..Pharmacotherapy is typically needed for control of high blood pressure, hypercoagulability, and increased levels of blood glucose and triglycerides...
  34. ncbi request reprint Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery
    Rohit Arora
    Department of Medicine, Robert Wood Johnson University Hospital, New Brunswick, New Jersey
    J Card Surg 21:198-204. 2006
    ....
  35. ncbi request reprint The Metabolic Syndrome in African Americans: a review
    W Dallas Hall
    African American Lipid and Cardiovascular Council, USA
    Ethn Dis 13:414-28. 2003
    ..This comprehensive review is provided as part of the educational activities of the African-American Lipid and Cardiovascular Council (AALCC)...
  36. ncbi request reprint Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy
    William C Cushman
    University of Tennessee College of Medicine and Veterans Affairs Medical Center, Memphis, TN, USA
    Am J Geriatr Cardiol 17:27-36. 2008
    ..Irbesartan/HCTZ combination therapy allowed SBP goal attainment in 73% of patients aged 65 years or older whose hypertension was previously uncontrolled with antihypertensive monotherapy...

Research Grants1

  1. Partnership Program to Reduce Cardiovascular Disparities
    Elijah Saunders; Fiscal Year: 2008
    ..We strongly expect improved outcomes/awareness of cardiovascular health among minority patients serviced by both BSBHS and UMB. ..